نتائج البحث - "Justin Kopit"

1

Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer

المصدر: Journal of Clinical Oncology. 35:3449-3457

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Kaplan-Meier Estimate, Carboplatin, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Outcome Assessment, Health Care, Aged, 80 and over, education.field_of_study, Hazard ratio, Antibodies, Monoclonal, Anemia, Middle Aged, Editorial, 030220 oncology & carcinogenesis, Female, Nivolumab, medicine.drug, Adult, Diarrhea, medicine.medical_specialty, Neutropenia, Paclitaxel, Population, Ipilimumab, Placebo, 03 medical and health sciences, Double-Blind Method, Internal medicine, medicine, Humans, Lung cancer, education, Aged, Proportional Hazards Models, Chemotherapy, business.industry, medicine.disease, 030104 developmental biology, chemistry, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6f0432af2fc9075a20f60c587536c17
https://doi.org/10.1200/jco.2016.71.7629

2

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, Medizin, Antineoplastic Agents, B7-H1 Antigen, Article, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Carcinoma, Clinical endpoint, Medicine, Humans, Survival analysis, Aged, Aged, 80 and over, Chemotherapy, Cetuximab, business.industry, Antibodies, Monoclonal, General Medicine, medicine.disease, Survival Analysis, 030104 developmental biology, Nivolumab, Docetaxel, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Quality of Life, Carcinoma, Squamous Cell, Female, Neoplasm Recurrence, Local, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37038f077698b3441478a42ea98a55cd
https://www.ncbi.nlm.nih.gov/pubmed/27718784

3

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1

المصدر: World journal of gastroenterology. 22(12)

مصطلحات موضوعية: Male, Pyrrolidines, Time Factors, Hepacivirus, viruses, Clinical Trials Study, Peginterferon-alfa, Viral Nonstructural Proteins, Telaprevir, Polyethylene Glycols, chemistry.chemical_compound, Liver disease, 0302 clinical medicine, Medicine, 030212 general & internal medicine, biology, Gastroenterology, Imidazoles, virus diseases, Valine, General Medicine, Middle Aged, Viral Load, Recombinant Proteins, Treatment Outcome, RNA, Viral, 030211 gastroenterology & hepatology, Drug Therapy, Combination, Female, Viral load, Oligopeptides, medicine.drug, Adult, Daclatasvir, Adolescent, Genotype, Alpha interferon, Antiviral Agents, 03 medical and health sciences, Young Adult, stomatognathic system, Chronic hepatitis C, Direct-acting antiviral, Genotype 1b, NS5A inhibitor, Aged, Drug Resistance, Viral, Hepatitis C, Chronic, Humans, Interferon-alpha, Interleukins, Polymorphism, Genetic, Ribavirin, business.industry, biochemical phenomena, metabolism, and nutrition, biology.organism_classification, medicine.disease, Virology, digestive system diseases, chemistry, Carbamates, Interferons, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab6cea35440a383d52096160a4ec2eb7
https://pubmed.ncbi.nlm.nih.gov/27022224

4

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

المساهمون: Dept. of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School [Hannover] (MHH), German Center for Infection Research - partner site Hannover-Braunschweig (DZIF), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Weill Medical College of Cornell University [New York], Hôpital Beaujon, Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Henry Ford Health System, China Medical University Taichung, National Cheng Kung University (NCKU), University of Colorado [Denver], Pusan National University, Universität Duisburg-Essen [Essen], Baylor College of Medicine (BCM), Baylor University, Kaiser Permanente, Service d'hépato-gastro-entérologie, Assistance Publique - Hôpitaux de Marseille (APHM), Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], Taipei Veterans General Hospital [Taiwan], National Yang-Ming University [Taipei, Taiwan], Monash University [Clayton], Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service d'Hépato-Gastro-Entérologie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Inje University, National Taiwan University Hospital, Bristol-Myers Squibb Company, Bristol-Myers Squibb., Hôpital Beaujon-Université Paris Diderot - Paris 7 (UPD7)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Hépato-Gastroentérologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP]

المصدر: The Lancet
The Lancet, Elsevier, 2014, 384 (9954), pp.1597-1605. ⟨10.1016/S0140-6736(14)61059-X⟩

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Daclatasvir, Pyrrolidines, Genotype, [SDV]Life Sciences [q-bio], Medizin, Administration, Oral, Peginterferon-alfa, Hepacivirus, Placebo, Antiviral Agents, 03 medical and health sciences, chemistry.chemical_compound, Young Adult, 0302 clinical medicine, Internal medicine, medicine, Humans, Adverse effect, Beclabuvir, Aged, Aged, 80 and over, Sulfonamides, business.industry, Ribavirin, Imidazoles, Valine, General Medicine, Hepatitis C, Chronic, Middle Aged, Isoquinolines, 3. Good health, Surgery, Discontinuation, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Asunaprevir, RNA, Viral, 030211 gastroenterology & hepatology, Drug Therapy, Combination, Female, Carbamates, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9ee111d62c1a85738c888a2067bc40
https://hal.univ-lorraine.fr/hal-01687214

5

Nivolumab (Nivo) vs investigator’s choice (IC) for platinum-refractory (PR) recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN; Checkmate 141): Outcomes in first-line (1L) R/m patients and updated safety and efficacy

المصدر: Journal of Clinical Oncology. 35:6019-6019

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3b12090e358438cd014dedc0d6d9ac31
https://doi.org/10.1200/jco.2017.35.15_suppl.6019

6

Abstract CT099: Nivolumab (nivo) vs investigator's choice (IC) for recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): CheckMate-141

المصدر: Cancer Research. 76:CT099-CT099

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::16e25b0fb306efe58dbada8e34f55f84
https://doi.org/10.1158/1538-7445.am2016-ct099

7

Further evaluations of nivolumab (nivo) versus investigator’s choice (IC) chemotherapy for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CheckMate 141

المصدر: Journal of Clinical Oncology. 34:6009-6009

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::15aae7b384db33a646c313968f0c1685
https://doi.org/10.1200/jco.2016.34.15_suppl.6009

8

P1300 EFFICACY AND SAFETY OF DACLATASVIR IN COMBINATION WITH ASUNAPREVIR (DCV+ASV) IN CIRRHOTIC AND NON-CIRRHOTIC PATIENTS WITH HCV GENOTYPE 1B: RESULTS OF THE HALLMARK DUAL STUDY

المؤلفون: Misti Linaberry, Jia-Horng Kao, Stephanie Noviello, Michael Manns, William Sievert, Boris Yoffe, Eric Hughes, Ira M. Jacobson, Fernando Bessone, Cheng Yuan Peng, Stuart K. Roberts, Ki Tae Yoon, Jeong Heo, Justin Kopit

المصدر: Journal of Hepatology. 60:S527-S528

مصطلحات موضوعية: medicine.medical_specialty, Daclatasvir, Hepatology, business.industry, Gastroenterology, Virology, chemistry.chemical_compound, Genotype 1b, chemistry, Internal medicine, medicine, Asunaprevir, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a863b4257a3e99346a289d6990aad477
https://doi.org/10.1016/s0168-8278(14)61467-7

View record from ScienceDirect

Full Text via ClinicalKey

9

O166 ALL-ORAL DUAL THERAPY WITH DACLATASVIR AND ASUNAPREVIR IN PATIENTS WITH HCV GENOTYPE 1B INFECTION: PHASE 3 STUDY RESULTS

المصدر: Journal of Hepatology. 60:S524-S525

مصطلحات موضوعية: medicine.medical_specialty, Daclatasvir, Hepatology, business.industry, Phases of clinical research, Gastroenterology, chemistry.chemical_compound, Genotype 1b, chemistry, Internal medicine, Asunaprevir, Medicine, In patient, Dual therapy, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a8061e594de69acf5a70d9bd4f8f4f6c
https://doi.org/10.1016/s0168-8278(14)61461-6

View record from ScienceDirect

Full Text via ClinicalKey

10

EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer

المساهمون: Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098) (RIGHT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté]), Saas, Philippe, Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté])-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)

المصدر: Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (14), pp.2311-9. ⟨10.1200/JCO.2007.13.1193⟩

مصطلحات موضوعية: Male, Cancer Research, Organoplatinum Compounds, Colorectal cancer, medicine.medical_treatment, Cetuximab, Gastroenterology, MESH: Antibodies, Monoclonal, 0302 clinical medicine, MESH: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Medicine, Neoplasm Metastasis, Aged, 80 and over, MESH: Aged, 0303 health sciences, MESH: Middle Aged, Hazard ratio, MESH: Organoplatinum Compounds, Antibodies, Monoclonal, Middle Aged, 3. Good health, ErbB Receptors, Oxaliplatin, MESH: Antineoplastic Combined Chemotherapy Protocols, Oncology, 030220 oncology & carcinogenesis, MESH: Camptothecin, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, [SDV.IMM] Life Sciences [q-bio]/Immunology, MESH: Receptor, Epidermal Growth Factor, Neutropenia, Antibodies, Monoclonal, Humanized, Irinotecan, Disease-Free Survival, 03 medical and health sciences, Internal medicine, Panitumumab, Humans, neoplasms, 030304 developmental biology, Aged, Chemotherapy, MESH: Humans, business.industry, MESH: Quality of Life, MESH: Adult, medicine.disease, MESH: Neoplasm Metastasis, digestive system diseases, MESH: Male, Surgery, Pyrimidines, MESH: Pyrimidines, MESH: Disease-Free Survival, Quality of Life, Camptothecin, business, MESH: Female, MESH: Colorectal Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::686c6b7f5b6cc581cf7b0c5b34a2a1aa
https://www.hal.inserm.fr/inserm-00484211

تنقيح النتائج